全文获取类型
收费全文 | 258689篇 |
免费 | 27033篇 |
国内免费 | 10123篇 |
专业分类
耳鼻咽喉 | 2888篇 |
儿科学 | 6207篇 |
妇产科学 | 3482篇 |
基础医学 | 43086篇 |
口腔科学 | 7403篇 |
临床医学 | 22496篇 |
内科学 | 37849篇 |
皮肤病学 | 5909篇 |
神经病学 | 15006篇 |
特种医学 | 6958篇 |
外国民族医学 | 132篇 |
外科学 | 22323篇 |
综合类 | 39428篇 |
现状与发展 | 62篇 |
一般理论 | 1篇 |
预防医学 | 16699篇 |
眼科学 | 5146篇 |
药学 | 20023篇 |
81篇 | |
中国医学 | 7878篇 |
肿瘤学 | 32788篇 |
出版年
2024年 | 261篇 |
2023年 | 3917篇 |
2022年 | 5543篇 |
2021年 | 9807篇 |
2020年 | 9706篇 |
2019年 | 9083篇 |
2018年 | 9340篇 |
2017年 | 9631篇 |
2016年 | 10161篇 |
2015年 | 10799篇 |
2014年 | 16824篇 |
2013年 | 18438篇 |
2012年 | 15843篇 |
2011年 | 17315篇 |
2010年 | 14016篇 |
2009年 | 13142篇 |
2008年 | 13446篇 |
2007年 | 13523篇 |
2006年 | 12197篇 |
2005年 | 10976篇 |
2004年 | 9580篇 |
2003年 | 8381篇 |
2002年 | 6876篇 |
2001年 | 6012篇 |
2000年 | 4923篇 |
1999年 | 4196篇 |
1998年 | 3509篇 |
1997年 | 3290篇 |
1996年 | 2717篇 |
1995年 | 2845篇 |
1994年 | 2589篇 |
1993年 | 2120篇 |
1992年 | 1704篇 |
1991年 | 1580篇 |
1990年 | 1260篇 |
1989年 | 1167篇 |
1988年 | 1060篇 |
1987年 | 836篇 |
1986年 | 794篇 |
1985年 | 1118篇 |
1984年 | 1056篇 |
1983年 | 726篇 |
1982年 | 782篇 |
1981年 | 622篇 |
1980年 | 535篇 |
1979年 | 437篇 |
1978年 | 307篇 |
1977年 | 241篇 |
1976年 | 235篇 |
1975年 | 121篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
91.
目的 调查中国农村居民的体力活动状况及其影响因素。方法 采用国际体力活动短问卷对分别代表中国东、中、西部的山东省、山西省和云南省3个省一共6个县的3 834名15岁以上农村居民的体力活动状况进行调查。结果 调查获得有效问卷3 780份,其中山东省1 251人(33.1%),山西省1 256人(33.2%),云南省1 273人(33.7%)。男性1 867人(49.4%),女性1 913人(50.6%)。农村居民高、中、低水平体力活动人数分别为1 691人(44.7%)、1 248人(33%)、841人(22.3%)。多因素非条件logistic回归分析结果显示,性别、年龄、职业、是否患慢性病以及地区是体力活动的影响因素。其中,男性(OR = 0.832,95%CI: 0.704~0.985)、年龄36~59岁的人群(OR = 0.760,95%CI: 0.625~0.925)为农村居民体力活动的保护因素;机关、企事业单位及离退休人员(OR = 1.469,95%CI: 1.017~2.124)、在校学生(OR = 1.925,95%CI: 1.127~3.286)、失业、无业人员(OR = 3.062,95%CI: 2.470~3.796)、患慢性病的人群(OR = 1.366,95%CI:1.133~1.645)为农村居民体力活动不足的危险因素。结论 女性、老年人、机关、企事业单位及离退休人员、在校学生、失业、无业人员、患慢性病的人群发生体力活动不足的可能性更高,针对中国不同地区农村居民体力活动的干预,应重点关注此类人群。 相似文献
92.
93.
94.
《Transfusion and apheresis science》2022,61(5):103447
BackgroundPatients' inflammatory history is an important factor underlying red blood cell (RBC) alloimmunization, which is a frequent transfusion complication among individuals with sickle cell disease (SCD). HLA-G has been associated with different inflammatory and auto - immune diseases. Our goal was to verify whether the HLA-G + 3142 C>G and 14-bp Ins/Del variations are associated with RBC antibody development among SCD patients.MethodsThis was a single-center case-control study. SCD patients were randomly selected for the study and divided into two groups: ‘Alloimmunized’ and ‘Nonalloimmunized’ depending on the presence of irregular antibodies. The ‘Alloimmunized’group was further divided into two subgroups according to the presence of only antibodies against the Rh and Kell blood group systems or the existence of antibodies to antigens of the other blood group systems.ResultsA total of 213 patients were included in the study (110 alloimmunized and 103 non-alloimmunized). The ‘Alloimmunized’ and ‘Non-alloimmunized’ groups did not differ statistically regarding the HLA-G + 14 bp Ins/Del ( p = 0.494) and + 3142 C>G ( p = 0.334). Individuals who had only antibodies against the Rh and Kell antigens had a frequency of HLA-G + 3142GG genotype almost twice as high compared to the groupwith antibodies against less immunogenic antigens ( p = 0.043).ConclusionsThe genotype frequency of HLA-G + 3142 C>G differs among alloimmunized SCD patients, depending on the presence of antibodies against low immunogenic RBC antigens. This highlights a possible role played by the HLA-G molecule in the RBC alloimmunization process. 相似文献
96.
Charles A. Johnson Jared J. Reid William E. Allen Suvleen K. Singh Josef K. Eichinger Richard J. Friedman 《Seminars in Arthroplasty》2022,32(3):594-599
BackgroundThe purpose of this study is to evaluate the effect of body mass index (BMI) on discharge to a postacute care (PAC) facility following elective total shoulder arthroplasty (TSA).MethodsThe National Surgical Quality Improvement Program database was queried to identify adult patients (>18 years old) who underwent inpatient TSA for primary osteoarthritis between 2005 and 2018. Hemiarthroplasty, revision TSA, trauma indications, and outpatient procedures were excluded. Patient and perioperative data were identified. Univariate analysis and multivariate logistic regression were used to assess the relationship between BMI and discharge to PAC facilities.ResultsA total of 10,198 patients with a primary TSA were identified. The majority (93%) of patients were discharged home vs. 7% to PAC facilities. Patients discharged to PAC had significantly higher mean BMI (P = .006). After controlling for demographic and comorbid factors, BMI was the only modifiable risk factor that was independently associated with an increased risk of discharge to a PAC. For every increase in BMI point, there was an increased risk of discharge to a PAC by 2.9% (odds ratio [OR] 1.029, confidence interval [CI] 1.016-1.041, P < .001). Additional covariates associated with PAC discharge were older age (OR 1.113, CI 1.099-1.127, P < .001), female gender (OR 3.037, CI 2.489-3.705, P < .001), and dependent functional status (OR 8.322, CI 5.544-12.492, P < .001).ConclusionMost patients undergoing TSA were discharged home following surgery. While age, sex, and functional status also affect disposition, elevated BMI is the only modifiable risk factor that independently predicts PAC discharge. Consideration of patient BMI prior to elective TSA may greatly improve discharge planning and management of patient expectations. 相似文献
97.
98.
ObjectivesMap regional lymph node metastases for lateralized oral cavity squamous cell carcinoma (OCSCC) and evaluate factors associated with regional metastases and recurrence.Materials and methodsRetrospective cohort study of 715 patients with lateralized OCSCC surgically treated in 1997–2011. Analysis was performed using log-rank, Kaplan-Meier, and multivariable logistic and Cox regression.ResultsRegional metastases were identified in ipsilateral levels IIA (24%), IB (18%), III (13%), V (9%), IV (7%), IA (2%) and IIB (1%) and the contralateral neck (3%). Lymphovascular invasion (LVI) (Hazard Ratio [HR] 2.2, 95% Confidence Interval [CI] 1.2–3.9) and T category (T3 vs. T1: HR 4.1, 95% CI 1.9–9.3; T4 vs. T1: HR 2.3, 95% CI 1.2–4.3) were associated with regional metastases. Most (71%) isolated regional metastatic recurrences were in undissected levels of the neck, including 58% in levels IV and V. Tumors of the hard palate (HR 4.3, 95% CI 1.2–16.1), upper alveolus (HR 3.2, 95% CI 1.0–4.7) or with LVI (HR 2.0, 95% CI 1.0–3.9) were associated with isolated regional recurrence. For upper alveolar/hard palate tumors, depth of invasion (DOI) ≥4 mm (P = .003) and LVI (P = .04) were associated with regional metastases.ConclusionsFor lateralized OCSCC, elective neck dissection of level IIB or the contralateral neck may rarely be needed, but additional surgical or radiation treatment of levels IV and V may be considered based on patient risk factors, including T category 3–4 or LVI. For upper alveolar/hard palate tumors, DOI ≥4 mm is an appropriate threshold for elective neck dissection. 相似文献
99.
Andrea Ferrari MD Daniel Orbach MD Michela Casanova MD Max M. van Noesel MD Pablo Berlanga MD Bernadette Brennan MD Nadege Corradini MD Reineke A. Schoot MD Gema L. Ramirez-Villar MD Lisa Lyngsie Hjalgrim MD Rita Alaggio MD Gabriela Guillen Burrieza MD Akmal Safwat MD Alison L. Cameron MD Rick R. van Rijn MD Veronique Minard-Colin MD Ilaria Zanetti BSc Gianni Bisogno MD Julia C. Chisholm MD Johannes H. M. Merks MD 《Cancer》2023,129(16):2542-2552
Background
Limited data exist on the clinical behavior of pediatric non-rhabdomyosarcoma soft tissue sarcomas (NRSTS) with distant metastases at onset, and a clear standard of care has not yet been defined.Methods
This cohort study reports on pediatric adult-type metastatic NRSTS enrolled in two concurrent prospective European studies, i.e., the randomized BERNIE study and the single-arm MTS 2008 study developed by the European paediatric Soft tissue sarcoma Study Group. Treatment programs were originally designed for patients with metastatic rhabdomyosarcoma, i.e., nine courses of multidrug chemotherapy (with or without bevacizumab in the BERNIE study), followed by 12 cycles of maintenance therapy, whereas radiotherapy and/or surgery (on primary tumor and/or metastases) were delayed until after seven courses of chemotherapy had been administered.Results
The study included 61 patients <21 years old treated from July 2008 to December 2016. The lung was the site of metastases in 75% of the cases. All patients received multi-agent chemotherapy, 44% had local therapy to primary tumor, and 18% had treatment of metastases. Median time to progression/relapse was 6 months. A high rate of tumor progression was observed during the initial part of the chemotherapy program. With a median follow-up of 41.5 months (range, 2–111 months), 3-year event-free survival and overall survival were 15.4% (95% confidence interval [CI], 7.6–25.7) and 34.9% (95% CI, 22.7–47.5), respectively. There were no statistically significant differences in outcome depending on the type of treatment administered.Conclusions
The study confirmed the overall poor outcome for patients with metastatic NRSTS, whose treatment remains a challenge.Plain Language Summary
- Pediatric non-rhabdomyosarcoma soft tissue sarcomas form a heterogeneous group of rare tumors.
- Although recent international studies have defined the standard of care for patients with localized disease, limited data are available on the clinical behavior of patients with distant metastases.
- This study on 61 metastatic cases treated on two prospective European protocols confirms that the chances of survival of such patients are often dismal and a standard treatment is still lacking.